Mycobacterium doricum sp. nov.

E. Tortoli, C. Piersimoni, R. M. Kroppenstedt, J. I. Montoya-Burgos, U. Reischl, A. Giacometti, S. Emler

Research output: Contribution to journalArticlepeer-review


A novel mycobacterial species is described in this study. The strain was isolated from the cerebrospinal fluid of a severely immunocompromised AIDS patient. It was scotochromogenic and slow-growing. Characteristic features for its differentiation from other mycobacteria are its lipid pattern and the unique gene sequences within the hypervariable regions of the 16S rDNA. The strain shows susceptibility to current antimycobacterial drugs. The pathogenicity of the novel mycobacterium and its clinical significance are not certain, as the neurological symptoms of the patient could also be due to concomitant infection with Cryptococcus neoformans. The name Mycobacterium doricum sp. nov. is proposed for the novel mycobacterium; the type strain is strain Fl-13295T (= DSM 44339T = CIP 106867T).

Original languageEnglish
Pages (from-to)2007-2012
Number of pages6
JournalInternational Journal of Systematic and Evolutionary Microbiology
Issue number6
Publication statusPublished - 2001


  • Identification
  • Mycobacterium doricum sp. nov.
  • Phylogeny
  • Taxonomy

ASJC Scopus subject areas

  • Microbiology
  • Applied Microbiology and Biotechnology
  • Ecology, Evolution, Behavior and Systematics
  • Immunology


Dive into the research topics of 'Mycobacterium doricum sp. nov.'. Together they form a unique fingerprint.

Cite this